Nanotechnology application for pain therapy

References

• Gottschalk A, Smith DS. New concepts in acute pain therapy: preemptive analgesia. Am Fam Physician. 2001;63:1979–1986.
   PubMed Web of Science ®Google Scholar
• Kehlet H, Dahl JB. The value of “multimodal” or “balanced analgesia” in postoperative pain treatment. Anesth Analg. 1993;77:1048–1056.
   PubMed Web of Science ®Google Scholar
• Conaghan PG. A turbulent decade for NSAIDs: update on current concepts of classification, epidemiology, comparative efficacy, and toxicity. Rheumatol Int. 2012;32:1491–1502.
   PubMed Web of Science ®Google Scholar
• D.Chen SL. Nanofibers used for the delivery of analgesics. Nanomedicine. 2015;10:1785–1800.
   PubMed Web of Science ®Google Scholar
• Koning GA, Schiffelers RM, Storm G. Endothelial cells at inflammatory sites as target for therapeutic intervention. Endothelium. 2002;9:161–171.
   PubMed Web of Science ®Google Scholar
• Hua S, Cabot PJ. Mechanisms of peripheral immune-cell-mediated analgesia in inflammation: clinical and therapeutic implications. Trends Pharmacol Sci. 2010;31:427–433.
   PubMed Web of Science ®Google Scholar
• de Paula E, Cereda CMS, Fraceto LF, et al. Micro and nanosystems for delivering local anesthetics. Expert Opin Drug Deliv. 2012;9:1505–1524.
   PubMed Web of Science ®Google Scholar
• Avnir Y, Ulmansky R, Wasserman V, et al. Amphipathic weak acid glucocorticoid prodrugs remote-loaded into sterically stabilized nanoliposomes evaluated in arthritic rats and in a Beagle dog: a novel approach to treating autoimmune arthritis. Arthritis Rheum. 2008;58:119–129.
   PubMed Web of Science ®Google Scholar
• Rittner HL, Stein C. Involvement of cytokines, chemokines and adhesion molecules in opioid analgesia. Eur J Pain. 2005;9:109–112.
   PubMed Web of Science ®Google Scholar
• Weston-Simons JS, Pandit H, Haliker V, et al. Intra-articular local anaesthetic on the day after surgery improves pain and patient satisfaction after Unicompartmental Knee Replacement: a randomised controlled trial. Knee. 2012;19:352–355.
   PubMed Web of Science ®Google Scholar
• Tarţaǎu L, Cazacu A, Melnig V. Ketoprofen-liposomes formulation for clinical therapy. J Mater Sci Mater Med. 2012;23:2499–2507.
   PubMed Web of Science ®Google Scholar
• Puglia C, Tirendi GG, Bonina F. Emerging role of colloidal drug delivery systems (CDDS) in NSAID topical administration. Curr Med Chem. 2013;20:1847–1857.
   PubMed Web of Science ®Google Scholar
• Raffin RP, Lima A, Lorenzoni R, et al. Natural lipid nanoparticles containing nimesulide: synthesis, characterization and in vivo antiedematogenic and antinociceptive activities. J Biomed Nanotechnol. 2012;8:309–315.
   PubMed Web of Science ®Google Scholar
• Dong J, Jiang D, Wang Z, et al. Intra-articular delivery of liposomal celecoxib-hyaluronate combination for the treatment of osteoarthritis in rabbit model. Int J Pharm. 2013;441:285–290.
   PubMed Web of Science ®Google Scholar
• Gorfine SR, Onel E, Patou G, et al. Bupivacaine extended-release liposome injection for prolonged postsurgical analgesia in patients undergoing hemorrhoidectomy: a multicenter, randomized, double-blind, placebo-controlled trial. Dis Colon Rectum. 2011;54:1552–1559.
   PubMed Web of Science ®Google Scholar
• Lafont ND, Legros FJ, Boogaerts JG. Use of liposome-associated bupivacaine in a cancer pain syndrome. Anaesthesia. 1996;51:578–579.
   PubMed Web of Science ®Google Scholar
• Puglia C, Trombetta D, Venuti V, et al. Evaluation of in-vivo topical anti-inflammatory activity of indometacin from liposomal vesicles. J Pharm Pharmacol. 2004;56:1225–1232.
   PubMed Web of Science ®Google Scholar
• Hua S, Cabot PJ. Targeted nanoparticles that mimic immune cells in pain control inducing analgesic and anti-inflammatory actions: a potential novel treatment of acute and chronic pain condition. Pain Physician. 2013;16:E199–E216.
   PubMed Web of Science ®Google Scholar
• Ward BB, Huang B, Desai A, et al. Sustained analgesia achieved through esterase-activated morphine prodrugs complexed with PAMAM dendrimer. Pharm Res. 2013;30:247–256.
   PubMed Web of Science ®Google Scholar
• Liu H, Ni J, Wang R. In vitro release performance and analgesic activity of endomorphin-1 loaded nanoparticles. Pharmazie. 2006;61:450–452.
   PubMed Web of Science ®Google Scholar
• Tosi G, Costantino L, Rivasi F, et al. Targeting the central nervous system: in vivo experiments with peptide-derivatized nanoparticles loaded with Loperamide and Rhodamine-123. J Control Release. 2007;122:1–9.
   PubMed Web of Science ®Google Scholar
• Grewal H, Dhakate SR, Goyal AK, et al. Development of transmucosal patch using nanofibers. Artif Cells Blood Substit Immobil Biotechnol. 2012;40:146–150.
   PubMed Web of Science ®Google Scholar
• Shen X, Yu D, Zhu L, et al. Electrospun diclofenac sodium loaded Eudragit® L 100-55 nanofibers for colon-targeted drug delivery. Int J Pharm. 2011;408:200–207.
   PubMed Web of Science ®Google Scholar
• Ngawhirunpat T, Opanasopit P, Rojanarata T, et al. Development of meloxicam-loaded electrospun polyvinyl alcohol mats as a transdermal therapeutic agent. Pharm Dev Technol. 2009;14:73–82.
   Web of Science ®Google Scholar
• Sathishkumar P, Chae JC, Unnithan AR, et al. Laccase-poly(lactic-co-glycolic acid) (PLGA) nanofiber: highly stable, reusable, and efficacious for the transformation of diclofenac. Enzyme Microb Technol. 2012;51:113–118.
   PubMed Web of Science ®Google Scholar
• Piras AM, Nikkola L, Chiellini F, et al. Development of diclofenac sodium releasing bio-erodible polymeric nanomats. J Nanosci Nanotechnol. 2006;6:3310–3320.
   PubMed Web of Science ®Google Scholar
• Souza MA, Sakamoto KY, Mattoso LHC. Release of the diclofenac sodium by nanofibers of poly(3-hydroxybutyrate- co -3-hydroxyvalerate) obtained from electrospinning and solution blow spinning. J Nanomater. 2014; DOI: 10.1155/2014/129035
   Web of Science ®Google Scholar
• Pamudji JS, Khairurrijal, Mauludin R, et al. PVA-ketoprofen nanofibers manufacturing using electrospinning method for dissolution improvement of ketoprofen. Nanotechnol Appl Energy Environ. 2013;737:166–175.
   Google Scholar
• Immich APS, Arias ML, Carreras N, et al. Drug delivery systems using sandwich configurations of electrospun poly(lactic acid) nanofiber membranes and ibuprofen. Mater Sci Eng C. 2013;33:4002–4008.
   PubMed Web of Science ®Google Scholar
• Heo DN, Lee JB, Bae MS, et al. Development of nanofiber coated indomethacin-eluting stent for tracheal regeneration. J Nanosci Nanotechnol. 2011;11:5711–5716.
   PubMed Web of Science ®Google Scholar
• Nikkola L, Seppala J, Harlin A, et al. Electrospun multifunctional diclofenac sodium releasing nanoscaffold. J Nanosci Nanotechnol. 2006;6:3290–3295.
   PubMed Web of Science ®Google Scholar
• Karthikeyan K, Guhathakarta S, Rajaram R, et al. Electrospun zein/eudragit nanofibers based dual drug delivery system for the simultaneous delivery of aceclofenac and pantoprazole. Int J Pharm. 2012;438:117–122.
   PubMed Web of Science ®Google Scholar
• Huang W, Zou T, Li S, et al. Drug-loaded zein nanofibers prepared using a modified coaxial electrospinning process. AAPS PharmSciTech. 2013;14:675–681.
   PubMed Web of Science ®Google Scholar
• Shi YL, Wei Z, Zhao H, et al. Electrospinning of ibuprofen-loaded composite nanofibers for improving the performances of transdermal patches. J Nanosci Nanotechnol. 2013;13:3855–3863.
   PubMed Web of Science ®Google Scholar
• Hou Z, Yang P, Lian H, et al. Multifunctional hydroxyapatite nanofibers and microbelts as drug carriers. Chemistry. 2009;15:6973–6982.
   PubMed Web of Science ®Google Scholar
• Peng H, Zhou S, Guo T, et al. In vitro degradation and release profiles for electrospun polymeric fibers containing paracetanol. Colloids Surf B Biointerfaces. 2008;66:206–212.
   PubMed Web of Science ®Google Scholar
• Tseng Y-Y, Liao J-Y, Chen W-A, et al. Biodegradable poly([D,L]-lactide-co-glycolide) nanofibers for the sustainable delivery of lidocaine into the epidural space after laminectomy. Nanomedicine (Lond). 2014;9:77–87.
   PubMed Web of Science ®Google Scholar
• Yu D-G, Branford-White C, White K, et al. Dissolution improvement of electrospun nanofiber-based solid dispersions for acetaminophen. AAPS PharmSciTech. 2010;11:809–817.
   PubMed Web of Science ®Google Scholar
• Chen DW, Hsu YH, Liao JY, et al. Sustainable release of vancomycin, gentamicin and lidocaine from novel electrospun sandwich-structured PLGA/collagen nanofibrous membranes. Int J Pharm. 2012;430:335–341.
   PubMed Web of Science ®Google Scholar
• Chen DWC, Liao JY, Liu SJ, et al. Novel biodegradable sandwich-structured nanofibrous drug-eluting membranes for repair of infected wounds: an in vitro and in vivo study. Int J Nanomedicine. 2012;7:763–771.
   PubMed Web of Science ®Google Scholar
• Wang Y, Wang B, Qiao W, et al. A novel controlled release drug delivery system for multiple drugs based on electrospun nanofibers containing nanoparticles. J Pharm Sci. 2010;99:4805–4811.
   PubMed Web of Science ®Google Scholar
• Lou T, Leung M, Wang X, et al. Bi-layer scaffold of chitosan/PCL-nanofibrous mat and PLLA-microporous disc for skin tissue engineering. J Biomed Nanotechnol. 2014;10:1105–1113.
   PubMed Web of Science ®Google Scholar
• Kau YC, Liao CC, Chen YC, et al. Sustained release of lidocaine from solvent-free biodegradable poly[(d,l)-lactide-co-glycolide] (PLGA): in vitro and in vivo study. Materials (Basel). 2014;7:6660–6676.
   PubMed Web of Science ®Google Scholar
• Merrell JG, McLaughlin SW, Tie L, et al. Curcumin-loaded poly(epsilon-caprolactone) nanofibres: diabetic wound dressing with anti-oxidant and anti-inflammatory properties. Clin Exp Pharmacol Physiol. 2009;36:1149–1156.
   PubMed Web of Science ®Google Scholar
• Li J, Kuang Y, Shi J, et al. The conjugation of nonsteroidal anti-inflammatory drugs (NSAID) to small peptides for generating multifunctional supramolecular nanofibers/hydrogels. Beilstein J Org Chem. 2013;9:908–917.
   PubMed Web of Science ®Google Scholar
• Mystakidou K, Katsouda E, Parpa E, et al. Oral transmucosal fentanyl citrate: overview of pharmacological and clinical characteristics. Drug Deliv. 2006;13:269–276.
   PubMed Web of Science ®Google Scholar
• Csaba N, Garcia-Fuentes M, Alonso M. The performance of nanocarriers for transmucosal drug delivery. Expert Opin Drug Deliv. 2006;3:463–478.
   PubMedGoogle Scholar
• Christie JM, Simmonds M, Patt R, et al. Dose-titration, multicenter study of oral transmucosal fentanyl citrate for the treatment of breakthrough pain in cancer patients using transdermal fentanyl for persistent pain. JCO. 1998;16:3238–3245.
   PubMed Web of Science ®Google Scholar
• Portenoy RK, Payne D, Jacobsen P. Breakthrough pain: characteristics and impact in patients with cancer pain. Pain. 1999;81:129–134.
   PubMed Web of Science ®Google Scholar
• Coluzzi PH, Schwartzberg L, Conroy JD Jr., et al. Break-through cancer pain: a randomized trial comparing oral transmucosal fentanyl citrate (OTFC®) and morphine sulfate immediate release (MSIR®). Pain. 2001; DOI: 10.1016/S0304-3959(00)00427-9
   PubMed Web of Science ®Google Scholar
• Payne R, Coluzzi P, Hart L, et al. Long-term safety of oral transmucosal fentanyl citrate for breakthrough cancer pain. J Pain Symptom Manage. 2001;22:575–583.
   PubMed Web of Science ®Google Scholar
• Burton AW, Driver LC, Mendoza TR, et al. Oral transmucosal fentanyl citrate in the outpatient management of severe cancer pain crises: a retrospective case series. Clin J Pain. 2004;20:195–197.
   PubMed Web of Science ®Google Scholar